FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:137-138 January 13, 1994 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Over the past five years, the Journal has published the results of several controlled trials of interferon alfa in the treatment of chronic viral hepatitis. The first three concerned hepatitis C^1,2 and hepatitis B³; interferon alfa is now widely used for the treatment of these common diseases. In this issue, Farci and her colleagues report on the use of interferon alfa to treat chronic hepatitis D⁴. They note that 50 percent of the patients in their study who were treated with high doses of interferon (9 million units three times weekly) had a complete response, as defined by . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kay, M. H., Wyllie, R. (1995). Therapeutic Applications of Alpha Interferon for Chronic Viral Hepatitis in Pediatric Patients. CLIN PEDIATR 34: 372-379